Abstract
Aim:
In this study, we investigated the regulatory effects of honokiol on various inflammatory events mediated by monocytes/macrophages (U937/RAW264.7 cells) and lymphocytes (splenic lymphocytes and CTLL-2 cells) and their putative action mechanism.
Methods:
In order to investigate the regulatory effects, various cell lines and primary cells (U937, RAW264.7, CTLL-2 cells, and splenic lymphocytes) were employed and various inflammatory events, such as the production of inflammatory mediators, cell adhesion, cell proliferation, and the early signaling cascade, were chosen.
Results:
Honokiol strongly inhibited various inflammatory responses, such as: (i) the upregulation of nitric oxide (NO), prostaglandin E2 and TNF-α production and costimulatory molecule CD80 induced by lipopolysaccharide (LPS); (ii) the functional activation of β1-integrin (CD29) assessed by U937 cell-cell and cell-fibronectin adhesions; (iii) the enhancement of lymphocytes and CD8+CTLL-2 cell proliferation stimulated by LPS, phytohemaglutinin A (PHA), and concanavalin A or interleukin (IL)-2; and (iv) the transcriptional upregulation of inducible NO synthase, TNF-α, cyclooxygenase-2, IL-12, and monocyte chemoattractant protein (MCP)-1. These anti-inflammatory effects of honokiol seem to be mediated by interrupting the early activated intracellular signaling molecule phosphoinositide 3-kinase (PI3K)/Akt, but not Src, the extracellular signal-regulated kinase, and p38, according to pharmacological, biochemical, and functional analyses.
Conclusion:
These results suggest that honokiol may act as a potent anti-inflammatory agent with multipotential activities due to an inhibitory effect on the PI3K/Akt pathway.
Similar content being viewed by others
Article PDF
References
Stafford JL, Neumann NF, Belosevic M . Macrophage-mediated innate host defense against protozoan parasites. Crit Rev Microbiol 2002; 28: 187–248.
Newman SL . Macrophages in host defense against Histoplasma capsulatum. Trends Microbiol 1999; 7: 67–71.
Shiloh MU, Nathan CF . Reactive nitrogen intermediates and the pathogenesis of Salmonella and mycobacteria. Curr Opin Microbiol 2000; 3: 35–42.
Cherayil BJ, Antos D . Inducible nitric oxide synthase and salmonella infection. Microbes Infect 2001; 3: 771–6.
Fujiwara N, Kobayashi K . Macrophages in inflammation. Curr Drug Targets Inflamm Allergy 2005; 4: 281–6.
Appel S, Mirakaj V, Bringmann A, Weck MM, Grunebach F, Brossart P . PPAR-gamma agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-kappaB pathways. Blood 2005; 106: 3888–94.
Ojaniemi M, Glumoff V, Harju K, Liljeroos M, Vuori K, Hallman M . Phosphatidylinositol 3-kinase is involved in Toll-like receptor 4-mediated cytokine expression in mouse macrophages. Eur J Immunol 2003; 33: 597–605.
Wang X, Wang Y, Geng Y, Li F, Zheng C . Isolation and purification of honokiol and magnolol from cortex Magnoliae officinalis by high-speed counter-current chromatography. J Chromatogr A 2004; 1036: 171–5.
Ou HC, Chou FP, Sheu WH, Hsu SL, Lee WJ . Protective effects of magnolol against oxidized LDL-induced apoptosis in endothelial cells. Arch Toxicol 2007; 81: 421–32.
Liou KT, Shen YC, Chen CF, Tsao CM, Tsai SK . Honokiol protects rat brain from focal cerebral ischemia-reperfusion injury by inhibiting neutrophil infiltration and reactive oxygen species production. Brain Res 2003; 992: 159–66.
Bang KH, Kim YK, Min BS, Na MK, Rhee YH, Lee JP, et al. Antifungal activity of magnolol and honokiol. Arch Pharm Res 2000; 23: 46–9.
Kong ZL, Tzeng SC, Liu YC . Cytotoxic neolignans: an SAR study. Bioorg Med Chem Lett 2005; 15: 163–6.
Lin YR, Chen HH, Ko CH, Chan MH . Neuroprotective activity of honokiol and magnolol in cerebellar granule cell damage. Eur J Pharmacol 2006; 537: 64–9.
Lee B, Kim CH, Moon SK . Honokiol causes the p21WAF1-mediated G(1)-phase arrest of the cell cycle through inducing p38 mitogen activated protein kinase in vascular smooth muscle cells. FEBS Lett 2006; 580: 5177–84.
Ishitsuka K, Hideshima T, Hamasaki M, Raje N, Kumar S, Hideshima H, et al. Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis. Blood 2005; 106: 1794–800.
Tse AK, Wan CK, Zhu GY, Shen XL, Cheung HY, Yang M, et al. Magnolol suppresses NF-kappaB activation and NF-kappaB regulated gene expression through inhibition of IkappaB kinase activation. Mol Immunol 2007; 44: 2647–58.
Tse AK, Wan CK, Shen XL, Yang M, Fong WF . Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation. Biochem Pharmacol 2005; 70: 1443–57.
Lee J, Jung E, Park J, Jung K, Lee S, Hong S, et al. Anti-inflammatory effects of magnolol and honokiol are mediated through inhibition of the downstream pathway of MEKK-1 in NF-kappaB activation signaling. Planta Med 2005; 71: 338–43.
Munroe ME, Arbiser JL, Bishop GA . Honokiol, a natural plant product, inhibits inflammatory signals and alleviates inflammatory arthritis. J Immunol 2007; 179: 753–63.
Cho JY, Chain BM, Vives J, Horejsi V, Katz DR . Regulation of CD43-induced U937 homotypic aggregation. Exp Cell Res 2003; 290: 155–67.
Cho JY, Baik KU, Jung JH, Park MH . In vitro anti-inflammatory effects of cynaropicrin, a sesquiterpene lactone, from Saussurea lappa. Eur J Pharmacol 2000; 398: 399–407.
Cho JY, Fox DA, Horejsi V, Sagawa K, Skubitz KM, Katz DR, et al. The functional interactions between CD98, beta1-integrins, and CD147 in the induction of U937 homotypic aggregation. Blood 2001; 98: 374–82.
Cho JY, Skubitz KM, Katz DR, Chain BM . CD98-dependent homotypic aggregation is associated with translocation of protein kinase Cdelta and activation of mitogen-activated protein kinases. Exp Cell Res 2003; 286: 1–11.
Larrucea S, Gonzalez-Rubio C, Cambronero R, Ballou B, Bonay P, Lopez-Granados E, et al. Cellular adhesion mediated by factor J, a complement inhibitor. Evidence for nucleolin involvement. J Biol Chem 1998; 273: 31718–25.
Bradford MM . A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248–54.
Raso GM, Pacilio M, Di Carlo G, Esposito E, Pinto L, Meli R . In-vivo and in-vitro anti-inflammatory effect of Echinacea purpurea and Hypericum perforatum. J Pharm Pharmacol 2002; 54: 1379–83.
Cieslik K, Zhu Y, Wu KK . Salicylate suppresses macrophage nitric-oxide synthase-2 and cyclo-oxygenase-2 expression by inhibiting CCAAT/enhancer-binding protein-beta binding via a common signaling pathway. J Biol Chem 2002; 277: 49304–10.
Berg J, Fellier H, Christoph T, Grarup J, Stimmeder D . The analgesic NSAID lornoxicam inhibits cyclooxygenase (COX)-1/-2, inducible nitric oxide synthase (iNOS), and the formation of interleukin (IL)-6 in vitro. Inflamm Res 1999; 48: 369–79.
Son HJ, Lee HJ, Yun-Choi HS, Ryu JH . Inhibitors of nitric oxide synthesis and TNF-alpha expression from Magnolia obovata in activated macrophages. Planta Med 2000; 66: 469–71.
Matsuda H, Kageura T, Oda M, Morikawa T, Sakamoto Y, Yoshikawa M . Effects of constituents from the bark of Magnolia obovata on nitric oxide production in lipopolysaccharide-activated macrophages. Chem Pharm Bull (Tokyo) 2001; 49: 716–20.
Cho JY, Park J, Kim PS, Yoo ES, Baik KU, Park MH . Savinin, a lignan from Pterocarpus santalinus inhibits tumor necrosis factor-alpha production and T cell proliferation. Biol Pharm Bull 2001; 24: 167–71.
Cho JY, Baik KU, Yoo ES, Yoshikawa K, Park MH . In vitro antiinflammatory effects of neolignan woorenosides from the rhizomes of Coptis japonica. J Nat Prod 2000; 63: 1205–9.
Cho JY, Yoo ES, Baik KU, Park MH, Han BH . In vitro inhibitory effect of protopanaxadiol ginsenosides on tumor necrosis factor (TNF)-alpha production and its modulation by known TNF-alpha antagonists. Planta Med 2001; 67: 213–8.
Park J, Lee J, Jung E, Park Y, Kim K, Park B, et al. In vitro antibacterial and anti-inflammatory effects of honokiol and magnolol against Propionibacterium sp. Eur J Pharmacol 2004; 496: 189–95.
Liou KT, Shen YC, Chen CF, Tsao CM, Tsai SK . The anti-inflammatory effect of honokiol on neutrophils: mechanisms in the inhibition of reactive oxygen species production. Eur J Pharmacol 2003; 475: 19–27.
Maulik N, Das DK . Redox signaling in vascular angiogenesis. Free Radic Biol Med 2002; 33: 1047–60.
Bharti AC, Aggarwal BB . Nuclear factor-kappa B and cancer: its role in prevention and therapy. Biochem Pharmacol 2002; 64: 883–8.
Bochkov VN, Leitinger N . Anti-inflammatory properties of lipid oxidation products. J Mol Med 2003; 81: 613–26.
Aggarwal BB, Sethi G, Ahn KS, Sandur SK, Pandey MK, Kunnumakkara AB, et al. Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution. Ann N Y Acad Sci 2006; 1091: 151–69.
Park EJ, Kim SY, Zhao YZ, Sohn DH . Honokiol reduces oxidative stress, c-jun-NH2-terminal kinase phosphorylation and protects against glycochenodeoxycholic acid-induced apoptosis in primary cultured rat hepatocytes. Planta Med 2006; 72: 661–4.
Ahn KS, Sethi G, Shishodia S, Sung B, Arbiser JL, Aggarwal BB . Honokiol potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through modulation of nuclear factor-kappaB activation pathway. Mol Cancer Res 2006; 4: 621–33.
Li L, Sampat K, Hu N, Zakari J, Yuspa SH . Protein kinase C negatively regulates Akt activity and modifies UVC-induced apoptosis in mouse keratinocytes. J Biol Chem 2006; 281: 3237–43.
Lou L, Urbani J, Ribeiro-Neto F, Altschuler DL . cAMP inhibition of Akt is mediated by activated and phosphorylated Rap1b. J Biol Chem 2002; 277: 32799–806.
Yamamoto Y, Gaynor RB . Role of the NF-kappaB pathway in the pathogenesis of human disease states. Curr Mol Med 2001; 1: 287–96.
Yamamoto Y, Gaynor RB . IkappaB kinases: key regulators of the NF-kappaB pathway. Trends Biochem Sci 2004; 29: 72–9.
Moissoglu K, Sachdev S, Gelman IH . Enhanced v-Src-induced oncogenic transformation in the absence of focal adhesion kinase is mediated by phosphatidylinositol 3-kinase. Biochem Biophys Res Commun 2005; 330: 673–84.
Caron RW, Yacoub A, Li M, Zhu X, Mitchell C, Hong Y, et al. Activated forms of H-RAS and K-RAS differentially regulate membrane association of PI3K, PDK-1, and AKT and the effect of therapeutic kinase inhibitors on cell survival. Mol Cancer Ther 2005; 4: 257–70.
Chen SZ, Jia H, Wu YH, Wang H . Pharmacokinetics of honokiol in rats. Beijing Da Xue Xue Bao 2004; 36: 41–4. Chinese.
Bai X, Cerimele F, Ushio-Fukai M, Waqas M, Campbell PM, Govindarajan B, et al. Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo. J Biol Chem 2003; 278: 35501–7.
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was supported by a Korea Research Foundation Grant (KRF-2006-C00455 to Jae Youl Cho).
Rights and permissions
About this article
Cite this article
Kim, B., Cho, J. Anti-inflammatory effect of honokiol is mediated by PI3K/Akt pathway suppression. Acta Pharmacol Sin 29, 113–122 (2008). https://doi.org/10.1111/j.1745-7254.2008.00725.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2008.00725.x
Keywords
This article is cited by
-
Honokiol Attenuates Sepsis-Associated Acute Kidney Injury via the Inhibition of Oxidative Stress and Inflammation
Inflammation (2019)
-
Neuraminidase 1 regulates proliferation, apoptosis and the expression of Cadherins in mammary carcinoma cells
Molecular and Cellular Biochemistry (2019)
-
E2F2 directly regulates the STAT1 and PI3K/AKT/NF-κB pathways to exacerbate the inflammatory phenotype in rheumatoid arthritis synovial fibroblasts and mouse embryonic fibroblasts
Arthritis Research & Therapy (2018)
-
Honokiol and Magnolol Inhibit CXCL10 and CXCL11 Production in IL-27-Stimulated Human Oral Epithelial Cells
Inflammation (2018)
-
Deep sequencing of Magnoliae officinalis reveals upstream genes related to the lignan biosynthetic pathway
Journal of Forestry Research (2017)